Minority Shareholder Remedies: Unfair Prejudice and Derivative Actions

If you hold a minority stake in a private company and the people in control are squeezing you out — diverting profits, excluding you from a management role you were promised, paying themselves but never declaring a dividend — you are not without a remedy. But you have to choose the right one. The two principal routes do very different jobs, and picking the wrong one can see your claim struck out, or leave you with an order that does not give you what you actually want after years of cost.

The two routes are the unfair prejudice petition (in Singapore, the oppression remedy) and the derivative action. The first is a personal remedy that usually ends in the majority or the company buying your shares at a fair price so you can leave. The second is the company's own claim, brought by you on its behalf, where any money recovered goes back into the company — not into your pocket. Getting that distinction right is the single most important decision in a minority shareholder dispute.

This guide explains both remedies across England & Wales, Hong Kong and Singapore: the governing provisions, the permission and leave hurdles, the relief on offer, and the costs you should plan for.

Two remedies, two different jobs

An unfair prejudice petition is a personal claim. You petition in your own name, complaining that the company's affairs have been conducted in a way that is unfairly prejudicial to your interests as a member. The wrong is to you, and the relief is usually that the respondents buy your shares so you can exit a relationship that has broken down. The company's loss is relevant only as evidence of the unfairness; the order is about you.

A derivative action is the opposite. The wrong is done to the company — typically a director's breach of duty, misappropriation of an opportunity, or self-dealing. Because the proper claimant for a wrong done to a company is, as a matter of common law, the company itself, a shareholder cannot ordinarily sue for it. The derivative action is the narrow exception: you bring the claim in the company's name, with the court's permission, and any recovery belongs to the company. You benefit only indirectly, through the value of your shareholding.

The consequences flow from that split. If your objective is to get out with the fair value of your stake, you want unfair prejudice. If you want a wrongdoing director made to restore money or assets to a company you intend to stay in, you want a derivative claim. Many disputes plead both, but they are not interchangeable, and a court will not let you use one to obtain the natural relief of the other.

England & Wales

Unfair prejudice: s.994

The unfair prejudice remedy is s.994 of the Companies Act 2006 (the successor to s.459 of the Companies Act 1985). A member may petition where:

the company's affairs are being or have been conducted in a manner that is unfairly prejudicial to the interests of members generally or of some part of its members (including at least himself).

The leading authority — and the only House of Lords decision on the provision — is O'Neill v Phillips [1999] 1 WLR 1092 (also reported at [1999] UKHL 24), where Lord Hoffmann anchored "unfairness" in established equitable principles rather than at large. Conduct is unfairly prejudicial where it breaches the terms on which the parties agreed to do business, whether those terms are in the articles and shareholders' agreement or in the informal understandings that underpin a quasi-partnership — a small company built on mutual trust, an expectation of participation in management, and restrictions on transferring shares. Disappointing those legitimate expectations can be unfair even where nothing in the formal constitution has been breached. But, as O'Neill v Phillips also makes clear, a member generally cannot complain of unfairness once the majority has made a reasonable offer to buy them out at a fair price.

The court's remedial powers sit in s.996 of the Companies Act 2006. Relief is at large — the court may make "such order as it thinks fit" — with a non-exhaustive statutory menu that includes ordering the purchase of the petitioner's shares (the buy-out, under s.996(2)(e)), regulating the conduct of the company's affairs in future, and restraining changes to the articles. Procedurally, a petition is governed by the Companies (Unfair Prejudice Applications) Proceedings Rules 2009 (SI 2009/2469), which dictate its form, presentation and service.

The statutory derivative claim: ss.260–264

The derivative claim is codified in ss.260–264 of the Companies Act 2006. Under s.260, the claim must be in respect of a cause of action vested in the company and arising from an actual or proposed act or omission involving negligence, default, breach of duty or breach of trust by a director. You cannot bring a company's contractual claim against a third party as a derivative action; the gateway is director wrongdoing.

Permission to continue is a deliberate two-stage filter designed to stop unmeritorious claims being run in the company's name:

Stage one — prima facie case (s.261). On the application alone, supported by the claimant's evidence only and with no input from the defendant, the court asks whether there is a prima facie case for permission. If there is not, the application is dismissed at this gate.
Stage two — the substantive hearing (s.263). If the claim survives, the court applies the s.263 criteria. Some are mandatory bars: permission must be refused if a person acting in accordance with the duty to promote the success of the company would not seek to continue the claim, or if the act has been authorised or ratified. Others are discretionary factors — the claimant's good faith, the company's own view of the claim, and whether the wrong could instead be pursued by the member in their own right (for instance, by an unfair prejudice petition).

s.262 covers the position where the company has itself begun the claim, and s.264 lets one member take over a derivative claim begun by another. In practice, the permission application is where the real fight happens.

Hong Kong

Hong Kong's regime mirrors the English structure but lives in the Companies Ordinance (Cap. 622), which came into operation on 3 March 2014. The unfair prejudice remedy was historically s.168A of the old Companies Ordinance (Cap. 32); it was carried forward and expanded into Part 14 of the new Ordinance.

Unfair prejudice: s.724

The current unfair prejudice provision is s.724 of Cap. 622 (Part 14, Division 2, "Unfair Prejudice to Interests of Members", ss.722–726). A member may petition under s.724(1) on essentially the same ground as in England — that the company's affairs are being or have been conducted in a manner unfairly prejudicial to the interests of members. The court's remedial power is at s.725: it may make any order it thinks fit, including ordering a buy-out of the petitioner's shares. The English authorities, including O'Neill v Phillips [1999] 1 WLR 1092, remain highly persuasive on what "unfair prejudice" means and on the quasi-partnership analysis.

The statutory derivative action: ss.731–738

Hong Kong's statutory derivative action is in Part 14, Division 4 of Cap. 622, at ss.731–738. A member needs the court's leave to bring or intervene in proceedings on the company's behalf, and that leave is granted under s.732. The important procedural precondition is in s.733: before applying, the member must serve 14 days' written notice on the company of the intention to apply for leave, stating the reasons (s.733(3) and (4)). So the right way to describe it is leave under s.732, subject to the s.733 notice — the two sections do different things, and missing the notice step is a common, avoidable defect.

Keep the two ordinances straight: the substantive shareholder remedies sit in Cap. 622, but just-and-equitable winding up — discussed below — remains in the older Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32).

Singapore

Oppression: s.216

Singapore frames the personal remedy as oppression under s.216 of the Companies Act 1967 (the 2020 Revised Edition of the Act formerly cited as Cap. 50 — the same statute, the same section number). It reaches conduct that is oppressive, in disregard of a member's interests, or that unfairly discriminates against or is otherwise prejudicial to a member. The touchstone is commercial unfairness, and the relief is at large: the court may, among other things, order a buy-out, regulate the company's affairs going forward, or order that the company be wound up.

The statutory derivative action: s.216A

The statutory derivative action is s.216A of the Companies Act 1967. A complainant applies to the court for leave under s.216A(2), and s.216A(3) sets three requirements that must be satisfied:

14 days' notice to the directors of the intention to apply for leave;
that the complainant is acting in good faith; and
that it appears to be prima facie in the interests of the company that the action be brought.

As in Hong Kong and England, the leave stage is the decisive battleground: a Singapore court will scrutinise good faith and the company's interest before letting a member litigate in its name.

The relief: buy-out, future conduct, or winding up

A share buy-out at fair value

In the great majority of successful unfair prejudice and oppression cases the order is a buy-out: the respondents purchase the petitioner's shares. That throws up two questions that are routinely worth more than the rest of the litigation combined.

The first is the minority discount. Shares carrying no control are, on an open-market sale, worth less per share than a controlling block. But where the company is a quasi-partnership and the petitioner is being bought out because the relationship has broken down through the majority's conduct, the courts will commonly value the shares as a rateable proportion of the whole undertaking — without a minority discount. Whether a discount applies turns on the nature of the company and how the petitioner came to be leaving; it is rarely a foregone conclusion.

The second is the valuation date. Is the company valued at the date the unfair conduct began, the date of the petition, the date of the order, or the date of trial? The answer can move the figure dramatically where the majority has run down or grown the business in the meantime. The court has a broad discretion (under s.996 in England, s.725 in Hong Kong, and s.216 in Singapore) to choose the date that produces a fair result, so the choice of date should be pleaded and evidenced deliberately, not left to the accountants alone.

Regulating future conduct

A buy-out is not the only option. The court can instead order the company's affairs to be conducted in a particular way in future — reinstating a director, requiring dividends, or restraining a transaction. This is the natural remedy where the petitioner intends to stay in the company rather than exit.

Just-and-equitable winding up as an alternative

Winding the company up on the just and equitable ground is the nuclear option, and it sits in a different statute in each jurisdiction:

England & Wales: s.122(1)(g) of the Insolvency Act 1986. A member may petition, but the court may decline a winding-up order where another remedy — typically a s.994 buy-out — would be more appropriate (see s.125(2)). Pleading winding up as the only relief, when a buy-out would do, is a recognised way to lose.
Hong Kong: s.177(1)(f) of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) — not Cap. 622.
Singapore: s.125(1)(i) of the Insolvency, Restructuring and Dissolution Act 2018, in force since 30 July 2020. This provision was moved out of the Companies Act; older sources still citing s.254(1)(i) of the Companies Act are out of date for petitions filed after that date.

Winding up destroys value and is usually a last resort, but the threat of it — and the court's willingness to grant it where trust has irretrievably broken down — is part of what makes a sensible buy-out worth taking.

Cost, funding and procedural risk

These are expensive cases, driven by forensic accounting and disclosure. Understand the cost mechanics before you issue.

In England, issuing carries a court fee. The published High Court fee to present a petition is £343, while starting a claim "for something other than money" — the usual vehicle for a Part 7 derivative claim — costs £646 (HMCTS fee schedule current to 10 July 2025). Which of those a s.994 petition attracts on issue is not coded consistently in the public sources, so check the current Civil Proceedings Fees Order before you file rather than relying on a single figure. In Hong Kong and Singapore, filing fees are set by the local court fee schedules and should be confirmed against those scales — do not assume the English figures apply.

Three cost points matter most. First, in a derivative action the claimant litigates for the company's benefit, and the court can — at the permission or leave stage — order the company to indemnify the claimant's costs, which materially changes the funding picture. Second, a respondent or the company may seek an order for security for costs against a minority claimant, particularly one who is impecunious or out of the jurisdiction, so think about funding early. Third, because the merits of these claims are tested at the permission, leave or directions stage, a weak claim is exposed to strike-out or summary judgment before trial. The eventual costs order at trial will, as usual, broadly follow the event, so a buy-out at a sensible price often beats fighting to judgment.

Choosing the right remedy

Start from what you want, not from the wrong you feel. If you want out at a fair price because the relationship has broken down, the unfair prejudice or oppression petition is your route, and your real work is on valuation — discount and date. If you want a director made to restore money or property to a company you intend to keep, the derivative action is the route, and your real work is clearing the permission or leave hurdle. If the company is deadlocked beyond saving, just-and-equitable winding up is the fallback — but expect the court to push you toward a buy-out if one is realistically available.

Pleading more than one route in the alternative is legitimate, but each carries its own threshold and its own natural relief, and a scattergun petition invites a strike-out application. Pleading precisely — the right section, the right facts, the relief you actually want — is what separates a claim that settles on good terms from one that drains years and costs.

If you are weighing up a minority shareholder dispute and want to pressure-test which remedy fits your facts and what relief is realistically available, you can ask CommonBench's Legal Chat to work through the options before you instruct.

This guide covers general principles of minority shareholder remedies in England & Wales, Hong Kong and Singapore, and is not legal advice on your situation. Procedure, fees and authority differ between courts and change over time. Check the current rules for your specific court before issuing a petition or applying for permission to bring a derivative claim.